Enhancement of radiosensitivity by a unique novel NF-&#954;B inhibitor, DHMEQ, in prostate cancer.

Kozakai, N; Kikuchi, E; Hasegawa, M; Suzuki, E; Ide, H; Miyajima, A; Horiguchi, Y; Nakashima, J; Umezawa, K; Shigematsu, N; Oya, M

Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer.

Kozakai, N; Kikuchi, E; Hasegawa, M; Suzuki, E; Ide, H; Miyajima, A; Horiguchi, Y; Nakashima, J; Umezawa, K; Shigematsu, N; Oya, M.

Affiliation

Kozakai N; Department of Urology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

Br J Cancer ; 107(4): 652-7, 2012 Aug 07.

Article in En | MEDLINE | ID: mdl-22805327

Subject(s)

Antineoplastic Agents/therapeutic use; Benzamides/pharmacology; Cyclohexanones/pharmacology; NF-kappa B/antagonists & inhibitors; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms/radiotherapy; Radiation-Sensitizing Agents/therapeutic use; Animals; Antineoplastic Agents/pharmacology; Benzamides/therapeutic use; Cell Cycle/drug effects; Cell Cycle/radiation effects; Cell Division/drug effects; Cell Division/radiation effects; Cell Line, Tumor; Cell Survival/drug effects; Cell Survival/radiation effects; Cyclohexanones/therapeutic use; Humans; Male; Mice; Mice, Nude; Radiation Tolerance/drug effects; Xenograft Model Antitumor Assays

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Radiation-Sensitizing Agents / Benzamides / NF-kappa B / Cyclohexanones / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Br J Cancer Year: 2012 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google